Samantha Marie Kanuck, PA-C

Samantha Kanuck practices at ENT and Allergy Associates of Florida in Boca Raton, Florida.

Samantha Kanuck's NPI, 1053803387, was assigned on June 1, 2018. Samantha Kanuck holds Georgia license 8782.

Samantha Kanuck's primary practice is ENT and Allergy Associates of Florida, at 900 NW 13th St, Boca Raton, FL 33486 in Palm Beach County. The practice phone is (561) 338-3267.

Samantha Kanuck's primary practice is ENT and Allergy Associates of Florida in Boca Raton, Florida. Samantha Kanuck is also affiliated with Wellington Regional Medical Center. The medical group on file is ENT & Allergy Associates of Florida. Dmand AI also links Samantha Kanuck to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Samantha Kanuck practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Samantha Kanuck's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Samantha Kanuck is licensed in Georgia.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, larynx and vocal cord disease, lower back pain and minor head injury among the conditions Samantha Kanuck treats.

CMS data shows 2,111 Medicare services from Samantha Kanuck across 12 procedure codes in 2024, for 728 Medicare patients. Medicare paid $130,901 for them. Every service was in an office.

CMS counts 728 Medicare patients who saw Samantha Kanuck in 2024. The largest group is 75 to 84, with 324 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Samantha Kanuck's median patient age at 71, with 60% women.

In 2024, Samantha Kanuck wrote 1,412 Medicare Part D claims for 594 patients. 99% of them were for generic drugs. CMS names the drug for 1,313 of them, across 21 drugs with 11 or more claims each, at $20,315 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Samantha Kanuck for performance year 2024, reported individually. Samantha Kanuck accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 24 general payments to Samantha Kanuck from 7 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $287.